Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™): interim guidance, first issued 10 February 2021, updated 21 April 2021, last updated 30 July 2021
Citation
(2021). Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™): interim guidance, first issued 10 February 2021, updated 21 April 2021, last updated 30 July 2021. World Health Organization. https://iris.who.int/handle/10665/343388. License: CC BY-NC-SA 3.0 IGO
Description
12 p.The Portuguese version is published by PAHO: https://iris.paho.org/handle/10665.2/54590
Document number
WHO/2019-nCoV/vaccines/SAGE_recommendation/AZD1222/2021.3Language
Englishالعربية
中文
português